The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
HIV‐1 neutralizing antibodies: understanding nature's pathways
Open accessAbstract
Summary: The development of an effective vaccine has been hindered by the enormous diversity of human immunodeficiency virus‐1 (HIV‐1) and its ability to escape a myriad of host immune responses. In addition, conserved vulnerable regions on the HIV‐1 envelope glycoprotein are often poorly immunogenic and elicit broadly neutralizing antibody responses (BNA bs) in a minority of HIV‐1‐infected individuals and only after several years of infection. All of the known BNA bs demonstrate high levels of somatic mutations and often display other unusual traits, such as a long heavy chain complementarity determining region 3 (CDRH 3) and autoreactivity that can be limited by host tolerance controls. Nonetheless, the demonstration that HIV‐1‐infected individuals can make potent BNA bs is encouraging, and recent progress in isolating such antibodies and mapping their immune pathways of development is providing new strategies for vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Self-citationIdentification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Self-citationRational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Self-citationBroad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
HIV preferentially infects HIV-specific CD4+ T cells
Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P., Kuruppu, J., Kunstman, K., Wolinsky, S., et al. (2002) · Nature · doi:10.1038/417095a · Cited by 1,262
Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Self-citationIsolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)
Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., et al. (1983) · Science · doi:10.1126/science.6601823 · Cited by 1,238
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Self-citationTiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationTiming the ancestor of the HIV-1 pandemic strains.
Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., & Bhattacharya, T. (2000) · Science · doi:10.1126/science.288.5472.1789 · Cited by 1,021
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-citationThe rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
The immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
Self-citationBroad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Self-citationBaba, T. W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W., Ayehunie, S., Cavacini, L. A., Posner, M. R., Katinger, H., Stiegler, G., et al. (2000) · Nature Medicine · doi:10.1038/72309 · Cited by 849
Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group (2006) · The Journal of Infectious Diseases · doi:10.1086/508748 · Cited by 847
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011) · Nature · doi:10.1038/nature10696 · Cited by 830
Self-citationVaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829 · cited 1×
“Despite this complexity, a necessary component of most effective viral vaccines is the induction of virus-specific antibodies that inactivate or neutralize the invading pathogen (1).”
BackgroundBroad and potent neutralization of HIV-1 by a gp41-specific human antibody
Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., et al. (2012) · Nature · doi:10.1038/nature11544 · Cited by 828
Self-citationZwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Wu, X., Zhou, T., Zhu, J., Zhang, B., Georgiev, I., Wang, C., Chen, X., Longo, N. S., Louder, M., McKee, K., et al. (2011) · Science · doi:10.1126/science.1207532 · Cited by 784
Self-citationMascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Self-citationAntibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
Starcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H., Parks, E. S., Parks, W. P., Josephs, S. F., Gallo, R. C., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90778-6 · Cited by 767
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
Self-citationBinley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13232-13252.2004 · Cited by 705
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Tomaras, G. D., Yates, N. L., Liu, P., Qin, L., Fouda, G. G., Chavez, L. L., Decamp, A. C., Parks, R. J., Ashley, V. C., Lucas, J. T., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01708-08 · Cited by 631
Self-citationPrincipal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., & Putney, S. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6768 · Cited by 618
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Hessell, A. J., Poignard, P., Hunter, M., Hangartner, L., Tehrani, D. M., Bleeker, W. K., Parren, P. W. H. I., Marx, P. A., & Burton, D. R. (2009) · Nature Medicine · doi:10.1038/nm.1974 · Cited by 546
Shibata, R., Igarashi, T., Haigwood, N., Buckler–White, A., Ogert, R., Ross, W., Willey, R., Cho, M. W., & Martin, M. A. (1999) · Nature Medicine · doi:10.1038/5568 · Cited by 539
Palker, T. J., Clark, M. E., Langlois, A. J., Matthews, T. J., Weinhold, K. J., Randall, R. R., Bolognesi, D. P., & Haynes, B. F. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.6.1932 · Cited by 532
Self-citationSather, D. N., Armann, J., Ching, L. K., Mavrantoni, A., Sellhorn, G., Caldwell, Z., Yu, X., Wood, B., Self, S., Kalams, S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02036-08 · Cited by 528
Structure of an unliganded simian immunodeficiency virus gp120 core
Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C., & Harrison, S. C. (2005) · Nature · doi:10.1038/nature03327 · Cited by 520
Goudsmit, J., Debouck, C., Meloen, R. H., Smit, L., Bakker, M., Asher, D. M., Wolff, A. V., Gibbs, C. J., & Gajdusek, D. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4478 · Cited by 500
Hessell, A. J., Rakasz, E. G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D. N., Koff, W. C., Watkins, D. I., & Burton, D. R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000433 · Cited by 497
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
Self-citationB-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Self-citationTrkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6609-6617.1995 · Cited by 480
Gray, E. S., Madiga, M. C., Hermanus, T., Moore, P. L., Wibmer, C. K., Tumba, N. L., Werner, L., Mlisana, K., Sibeko, S., Williamson, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00198-11 · Cited by 466
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Kwong, P. D., & Mascola, J. R. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.012 · Cited by 455
Self-citationNeutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients
Weiss, R. A., Clapham, P. R., Cheingsong-Popov, R., Dalgleish, A. G., Carne, C. A., Weller, I. V. D., & Tedder, R. S. (1985) · Nature · doi:10.1038/316069a0 · Cited by 452
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
GP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene
Veronese, F. D., DeVico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1985) · Science · doi:10.1126/science.2994223 · Cited by 437
Mascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.2.340 · Cited by 436
Self-citationHuman antibodies from transgenic animals.
Lonberg, N. (2005) · Nature Biotechnology · doi:10.1038/nbt1135 · Cited by 434
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex
Robert-Guroff, M., Brown, M., & Gallo, R. C. (1985) · Nature · doi:10.1038/316072a0 · Cited by 431
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430
Self-citationPolyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Mouquet, H., Scheid, J. F., Zoller, M. J., Krogsgaard, M., Ott, R. G., Shukair, S., Artyomov, M. N., Pietzsch, J., Connors, M., Pereyra, F., et al. (2010) · Nature · doi:10.1038/nature09385 · Cited by 427
Corti, D., Langedijk, J. P. M., Hinz, A., Seaman, M. S., Vanzetta, F., Fernandez-Rodriguez, B. M., Silacci, C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008805 · Cited by 426
Bonsignori, M., Hwang, K.-K., Chen, X., Tsao, C.-Y., Morris, L., Gray, E., Marshall, D. J., Crump, J. A., Kapiga, S. H., Sam, N. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05045-11 · Cited by 423
Self-citationIncreased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Rolland, M., Edlefsen, P. T., Larsen, B. B., Tovanabutra, S., Sanders-Buell, E., Hertz, T., deCamp, A. C., Carrico, C., Menis, S., Magaret, C. A., et al. (2012) · Nature · doi:10.1038/nature11519 · Cited by 417
Albert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nyström, G., & Fenyö, E. M. (1990) · AIDS · doi:10.1097/00002030-199002000-00002 · Cited by 398
Tomaras, G. D., Ferrari, G., Shen, X., Alam, S. M., Liao, H.-X., Pollara, J., Bonsignori, M., Moody, M. A., Fong, Y., Chen, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301456110 · Cited by 394
Self-citationThe Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Self-citationBroad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
Self-citationLiao, H.-X., Bonsignori, M., Alam, S. M., McLellan, J. S., Tomaras, G. D., Moody, M. A., Kozink, D. M., Hwang, K.-K., Chen, X., Tsao, C.-Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.011 · Cited by 377
Self-citationA Blueprint for HIV Vaccine Discovery
Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., Kaufmann, D. E., McElrath, M. J., Nussenzweig, M. C., Pulendran, B., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.008 · Cited by 375
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Diskin, R., Scheid, J. F., Marcovecchio, P. M., West, A. P., Klein, F., Gao, H., Gnanapragasam, P. N. P., Abadir, A., Seaman, M. S., Nussenzweig, M. C., et al. (2011) · Science · doi:10.1126/science.1213782 · Cited by 375
Bonsignori, M., Pollara, J., Moody, M. A., Alpert, M. D., Chen, X., Hwang, K.-K., Gilbert, P. B., Huang, Y., Gurley, T. C., Kozink, D. M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01023-12 · Cited by 375
Self-citationWalker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., Zwick, M. B., Phogat, S. K., Poignard, P., & Burton, D. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001028 · Cited by 370
Li, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01730-06 · Cited by 359
Gilbert, P. B., Peterson, M. L., Follmann, D., Hudgens, M. G., Francis, D. P., Gurwith, M., Heyward, W. L., Jobes, D. V., Popovic, V., Self, S. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428405 · Cited by 355
Robey, W. G., Safai, B., Oroszlan, S., Arthur, L. O., Gonda, M. A., Gallo, R. C., & Fischinger, P. J. (1985) · Science · doi:10.1126/science.2984774 · Cited by 349
Doria-Rose, N. A., Klein, R. M., Daniels, M. G., O'Dell, S., Nason, M., Lapedes, A., Bhattacharya, T., Migueles, S. A., Wyatt, R. T., Korber, B. T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01482-09 · Cited by 336
Self-citationIdentifying epitopes of HIV-1 that induce protective antibodies
Zolla-Pazner, S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1307 · Cited by 326
Pilgrim, A. K., Pantaleo, G., Cohen, O. J., Fink, L. M., Zhou, J. Y., Zhou, J. T., Bolognesi, D. P., Fauci, A. S., & Montefiori, D. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/516508 · Cited by 326
Doria-Rose, N. A., Klein, R. M., Manion, M. M., O'Dell, S., Phogat, A., Chakrabarti, B., Hallahan, C. W., Migueles, S. A., Wrammert, J., Ahmed, R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01583-08 · Cited by 318
Self-citationCharacteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Mikell, I., Sather, D. N., Kalams, S. A., Altfeld, M., Alter, G., & Stamatatos, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001251 · Cited by 315
Role of BCR affinity in T cell–dependent antibody responses in vivo
Yang Shih, T.-A., Meffre, E., Roederer, M., & Nussenzweig, M. C. (2002) · Nature Immunology · doi:10.1038/ni803 · Cited by 304
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Chen, L., Do Kwon, Y., Zhou, T., Wu, X., O’Dell, S., Cavacini, L., Hessell, A. J., Pancera, M., Tang, M., Xu, L., et al. (2009) · Science · doi:10.1126/science.1175868 · Cited by 300
Self-citationAntibody vs. HIV in a clash of evolutionary titans
Burton, D. R., Stanfield, R. L., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505126102 · Cited by 299
Variable and conserved neutralization antigens of human immunodeficiency virus
Weiss, R. A., Clapham, P. R., Weber, J. N., Dalgleish, A. G., Lasky, L. A., & Berman, P. W. (1986) · Nature · doi:10.1038/324572a0 · Cited by 298
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
Moore, P. L., Gray, E. S., Wibmer, C. K., Bhiman, J. N., Nonyane, M., Sheward, D. J., Hermanus, T., Bajimaya, S., Tumba, N. L., Abrahams, M.-R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2985 · Cited by 285
Montefiori, D. C., Karnasuta, C., Huang, Y., Ahmed, H., Gilbert, P., de Souza, M. S., McLinden, R., Tovanabutra, S., Laurence-Chenine, A., Sanders-Buell, E., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis367 · Cited by 284
Self-citationSun, Z.-Y. J., Oh, K. J., Kim, M., Yu, J., Brusic, V., Song, L., Qiao, Z., Wang, J.-H., Wagner, G., & Reinherz, E. L. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.018 · Cited by 279
Elicitation of structure-specific antibodies by epitope scaffolds
Ofek, G., Guenaga, F. J., Schief, W. R., Skinner, J., Baker, D., Wyatt, R., & Kwong, P. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004728107 · Cited by 278
Human Immunodeficiency Virus Type 1 Recombination: Rate, Fidelity, and Putative Hot Spots
Zhuang, J., Jetzt, A. E., Sun, G., Yu, H., Klarmann, G., Ron, Y., Preston, B. D., & Dougherty, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11273-11282.2002 · Cited by 262
Xiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Induction of HTLV-III/LAV from a Nonvirus-Producing T-Cell Line: Implications for Latency
Folks, T., Powell, D. M., Lightfoote, M. M., Benn, S., Martin, M. A., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3003906 · Cited by 260
Alam, S. M., McAdams, M., Boren, D., Rak, M., Scearce, R. M., Gao, F., Camacho, Z. T., Gewirth, D., Kelsoe, G., Chen, P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4424 · Cited by 260
Self-citationRole of HIV membrane in neutralization by two broadly neutralizing antibodies
Alam, S. M., Morelli, M., Dennison, S. M., Liao, H.-X., Zhang, R., Xia, S.-M., Rits-Volloch, S., Sun, L., Harrison, S. C., Haynes, B. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908713106 · Cited by 250
Self-citationAsymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
Julien, J.-P., Lee, J. H., Cupo, A., Murin, C. D., Derking, R., Hoffenberg, S., Caulfield, M. J., King, C. R., Marozsan, A. J., Klasse, P. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217537110 · Cited by 247
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus
Chakrabarti, S., Robert-Guroff, M., Wong-Staal, F., Gallo, R. C., & Moss, B. (1986) · Nature · doi:10.1038/320535a0 · Cited by 238
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
Li, Y., O'Dell, S., Walker, L. M., Wu, X., Guenaga, J., Feng, Y., Schmidt, S. D., McKee, K., Louder, M. K., Ledgerwood, J. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00754-11 · Cited by 235
Self-citationMoore, P. L., Ranchobe, N., Lambson, B. E., Gray, E. S., Cave, E., Abrahams, M.-R., Bandawe, G., Mlisana, K., Abdool Karim, S. S., Williamson, C., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000598 · Cited by 233
West, A. P., Diskin, R., Nussenzweig, M. C., & Bjorkman, P. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208984109 · Cited by 231
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
Azoitei, M. L., Correia, B. E., Ban, Y.-E. A., Carrico, C., Kalyuzhniy, O., Chen, L., Schroeter, A., Huang, P.-S., McLellan, J. S., Kwong, P. D., et al. (2011) · Science · doi:10.1126/science.1209368 · Cited by 224
Pancera, M., McLellan, J. S., Wu, X., Zhu, J., Changela, A., Schmidt, S. D., Yang, Y., Zhou, T., Phogat, S., Mascola, J. R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00966-10 · Cited by 224
Self-citationCorreia, B. E., Ban, Y.-E. A., Holmes, M. A., Xu, H., Ellingson, K., Kraft, Z., Carrico, C., Boni, E., Sather, D. N., Zenobia, C., et al. (2010) · Structure · doi:10.1016/j.str.2010.06.010 · Cited by 218
Barnett, S. W., Lu, S., Srivastava, I., Cherpelis, S., Gettie, A., Blanchard, J., Wang, S., Mboudjeka, I., Leung, L., Lian, Y., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5526-5540.2001 · Cited by 216
Self-citationA method for identification of HIV gp140 binding memory B cells in human blood
Scheid, J. F., Mouquet, H., Feldhahn, N., Walker, B. D., Pereyra, F., Cutrell, E., Seaman, M. S., Mascola, J. R., Wyatt, R. T., Wardemann, H., et al. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.11.012 · Cited by 214
Self-citationLiao, H.-X., Chen, X., Munshaw, S., Zhang, R., Marshall, D. J., Vandergrift, N., Whitesides, J. F., Lu, X., Yu, J.-S., Hwang, K.-K., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110363 · Cited by 204
Self-citationDal Porto, J. M., Haberman, A. M., Kelsoe, G., & Shlomchik, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011550 · Cited by 201
Verkoczy, L., Diaz, M., Holl, T. M., Ouyang, Y.-B., Bouton-Verville, H., Alam, S. M., Liao, H.-X., Kelsoe, G., & Haynes, B. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912914107 · Cited by 190
Self-citationHIV infection of the genital mucosa in women
Hladik, F., & Hope, T. J. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0004-1 · Cited by 184
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
Hoot, S., McGuire, A. T., Cohen, K. W., Strong, R. K., Hangartner, L., Klein, F., Diskin, R., Scheid, J. F., Sather, D. N., Burton, D. R., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003106 · Cited by 184
Zolla-Pazner, S., deCamp, A. C., Cardozo, T., Karasavvas, N., Gottardo, R., Williams, C., Morris, D. E., Tomaras, G., Rao, M., Billings, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053629 · Cited by 183
Self-citationWang, S., Kennedy, J. S., West, K., Montefiori, D. C., Coley, S., Lawrence, J., Shen, S., Green, S., Rothman, A. L., Ennis, F. A., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.024 · Cited by 180
The Antibody Response against HIV-1
Overbaugh, J., & Morris, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007039 · Cited by 177
Shaping of Human Germline IgH Repertoires Revealed by Deep Sequencing
Larimore, K., McCormick, M. W., Robins, H. S., & Greenberg, P. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201303 · Cited by 175
Bonsignori, M., Montefiori, D. C., Wu, X., Chen, X., Hwang, K.-K., Tsao, C.-Y., Kozink, D. M., Parks, R. J., Tomaras, G. D., Crump, J. A., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07163-11 · Cited by 175
Self-citationAntigen Drives Very Low Affinity B Cells to Become Plasmacytes and Enter Germinal Centers
Dal Porto, J. M., Haberman, A. M., Shlomchik, M. J., & Kelsoe, G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5373 · Cited by 171
Antibody polyspecificity and neutralization of HIV-1: A hypothesis
Haynes, B. F., Moody, M. A., Verkoczy, L., Kelsoe, G., & Alam, S. M. (2006) · Human Antibodies · doi:10.3233/hab-2005-143-402 · Cited by 163
Self-citationRational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1
Kwong, P. D., Mascola, J. R., & Nabel, G. J. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007278 · Cited by 159
Self-citationAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.3.347 · Cited by 155
Self-citationNeutralizing antibodies to HIV-1 induced by immunization
McCoy, L. E., & Weiss, R. A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121827 · Cited by 155
Deeks, S. G., Schweighardt, B., Wrin, T., Galovich, J., Hoh, R., Sinclair, E., Hunt, P. W., McCune, J. M., Martin, J. N., Petropoulos, C. J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00093-06 · Cited by 155
HIV-1 antibody — debris or virion?
Parren, P. W. H. I., Burton, D. R., & Sattentau, Q. J. (1997) · Nature Medicine · doi:10.1038/nm0497-366d · Cited by 153
Meffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M. C., & Schiff, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13051 · Cited by 152
Srivastava, I. K., Stamatatos, L., Kan, E., Vajdy, M., Lian, Y., Hilt, S., Martin, L., Vita, C., Zhu, P., Roux, K. H., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11244-11259.2003 · Cited by 147
Wrin, T., Loh, T. P., Vennari, J., Schuitemaker, H., & Nunberg, J. H. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.39-48.1995 · Cited by 142
An HIV Vaccine — Challenges and Prospects
Johnston, M. I., & Fauci, A. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0806162 · Cited by 130
Briney, B. S., Willis, J. R., & Crowe, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036750 · Cited by 129
Dey, B., Svehla, K., Xu, L., Wycuff, D., Zhou, T., Voss, G., Phogat, A., Chakrabarti, B. K., Li, Y., Shaw, G. M., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000445 · Cited by 122
Self-citationMehandru, S., Vcelar, B. A., Wrin, T., Stiegler, G. M., Joos, B., Mohri, H., Boden, D., Galovich, J., Tenner‐Racz, K., Rácz, P., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01340-07 · Cited by 120
Sundling, C., Li, Y., Huynh, N., Poulsen, C., Wilson, R., O'Dell, S. J., Feng, Y., Mascola, J. R., Wyatt, R. T., & Hedestam, G. B. K. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003752 · Cited by 116
Self-citationWest, A. P., Diskin, R., Nussenzweig, M. C., & Björkman, P. J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-s2-o33 · Cited by 114
Ofek, G., McKee, K., Yang, Y., Yang, Z., Skinner, J., Guenaga, J., Wyatt, R. T., Zwick, M. B., Nabel, G. J., Mascola, J. R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02257-09 · Cited by 111
Self-citationMascola, J. R., Louder, M. K., Winter, C., Prabhakara, R., Rosa, S. C. D., Douek, D. C., Hill, B. J., Gabuzda, D. H., & Roederer, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4810-4821.2002 · Cited by 108
Self-citationSong, L., Sun, Z.-Y. J., Coleman, K. E., Zwick, M. B., Gach, J. S., Wang, J., Reinherz, E. L., Wagner, G., & Kim, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901474106 · Cited by 107
Ivanov, I. I., Schelonka, R. L., Zhuang, Y., Gartland, G. L., Zemlin, M., & Schroeder, H. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7773 · Cited by 106
Dey, B., Pancera, M., Svehla, K., Shu, Y., Xiang, S.-H., Vainshtein, J. M., Li, Y., Sodroski, J., Kwong, P. D., Mascola, J. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02500-06 · Cited by 105
Self-citationWang, S., Kennedy, J. S., West, K., Montefiori, D. C., Coley, S., Lawrence, J., Shen, S., Green, S., Rothman, A. L., Ennis, F. A., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.060 · Cited by 105
Sundling, C., Forsell, M. N. E., O'Dell, S. J., Feng, Y., Chakrabarti, B. K., Rao, S. S., Loré, K., Mascola, J. R., Wyatt, R. T., Douagi, I., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100025 · Cited by 103
Self-citationRole of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies
Verkoczy, L. K., Kelsoe, G. H., Moody, M. A., & Haynes, B. F. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.04.003 · Cited by 100
Self-citationBeddows, S. A., Franti, M., Dey, A., Kirschner, M. W., Iyer, S. P. N., Fisch, D., Ketas, T. A., Yuste, E., Desrosiers, R. C., Klasse, P. J., et al. (2006) · Virology · doi:10.1016/j.virol.2006.10.032 · Cited by 100
Verkoczy, L. K., Chen, Y., Bouton-Verville, H., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101633 · Cited by 98
Cho, M. W., Kim, Y. B., Lee, M. K., Gupta, K. C., Ross, W. G., Plishka, R. J., Buckler-White, A. J., Igarashi, T., Theodore, T., Byrum, R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2224-2234.2001 · Cited by 94
Pal, R., Wang, S., Kalyanaraman, V. S., Nair, B. C., Whitney, S., Keen, T., Hocker, L., Hudacik, L., Rose, N., Mboudjeka, I., et al. (2006) · Virology · doi:10.1016/j.virol.2005.12.029 · Cited by 94
Self-citationWu, X., Zhou, T., O'Dell, S. J., Wyatt, R. T., Kwong, P. D., & Mascola, J. R. (2009) · Journal of Virology · doi:10.1128/jvi.01142-09 · Cited by 94
Self-citationAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
Haynes, B. F., & Montefiori, D. C. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.4.579 · Cited by 94
Self-citationBreden, F. J., Lepik, C., Longo, N. S., Montero, M., Lipsky, P. E., & Scott, J. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016857 · Cited by 92
Tong, T., Crooks, E. T., Osawa, K., & Binley, J. Μ. (2012) · Journal of Virology · doi:10.1128/jvi.06938-11 · Cited by 86
Ma, B.-J., Alam, S. M., Go, E. P., Lu, X., Desaire, H., Tomaras, G. D., Bowman, C. M., Sutherland, L. L., Scearce, R. M., Santra, S., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002200 · Cited by 85
Self-citationDoria‐Rose, N. A., Georgiev, I. S., O'Dell, S. J., Chuang, G., Staupe, R. P., McLellan, J. S., Gorman, J., Pancera, M., Bonsignori, M., Haynes, B. F., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00696-12 · Cited by 82
Self-citationBriney, B. S., Willis, J. R., McKinney, B. A., & Crowe, J. E. (2012) · Genes and Immunity · doi:10.1038/gene.2012.20 · Cited by 77
HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages
Moody, M. A., Yates, N. L., Amos, J. D., Drinker, M. S., Eudailey, J., Gurley, T. C., Marshall, D. J., Whitesides, J. F., Chen, X., Foulger, A., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00426-12 · Cited by 77
Self-citationJulien, J., Huarte, N., Maeso, R., Taneva, S. G., Cunningham, A., Nieva, J. L., & PAI, E. F. (2010) · Journal of Virology · doi:10.1128/jvi.02357-09 · Cited by 77
Blish, C. A., Nedellec, R., Mandaliya, K. N., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32805e8727 · Cited by 74
Salzwedel, K., & Berger, E. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230438497 · Cited by 73
Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
Xiao, X., Chen, W., Feng, Y., & Dimitrov, D. S. (2009) · Viruses · doi:10.3390/v1030802 · Cited by 71
Yang, X., Tomov, V., Kurteva, S., Wang, L., Ren, X., Górny, M. K., Zolla‐Pazner, S., & Sodroski, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12975-12986.2004 · Cited by 69
Briney, B. S., Willis, J. R., Hicar, M. D., Thomas, J. W., & Crowe, J. E. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03605.x · Cited by 65
Lynch, R. M., Rong, R., Boliar, S., Sethi, A., Li, B., Mulenga, J., Allen, S. A., Robinson, J. E., Gnanakaran, S., & Derdeyn, C. A. (2010) · Journal of Virology · doi:10.1128/jvi.02006-10 · Cited by 62
Zhu, J., O'Dell, S., Ofek, G., Pancera, M., Wu, X., Zhang, B., Zhang, Z., Mullikin, J. C., Simek, M., Burton, D. R., et al. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00315 · Cited by 60
Self-citationHomotypic antibody responses to fresh clinical isolates of human immunodeficiency virus
Montefiori, D. C., Zhou, J., Barnes, B., Lake, D. F., Hersh, E. M., Masuho, Y., & Lefkowitz, L. B. (1991) · Virology · doi:10.1016/0042-6822(91)90604-a · Cited by 59
Journal of AIDS & Clinical Research
Kong, L., & Sattentau, Q. J. (2019) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113 · Cited by 59
Mörner, A., Douagi, I., Forsell, M. N. E., Sundling, C., Dosenovic, P., O'Dell, S. J., Dey, B., Kwong, P. D., Voss, G., Thorstensson, R., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01102-08 · Cited by 59
Self-citationLessons from Failure—Preparing for Future HIV‐1 Vaccine Efficacy Trials
Graham, B. S., & Mascola, J. R. (2005) · The Journal of Infectious Diseases · doi:10.1086/428406 · Cited by 53
Self-citationVcelar, B. A., Stiegler, G. M., Wolf, H. M., Muntean, W. E., Leschnik, B., Mehandru, S., Markowitz, M. H., Armbruster, C., Kunert, R., Eibl, M. M., et al. (2007) · AIDS · doi:10.1097/qad.0b013e328285da15 · Cited by 48
Douagi, I., Forsell, M. N. E., Sundling, C., O'Dell, S. J., Feng, Y., Dosenovic, P., Li, Y., Seder, R. A., Loré, K., Mascola, J. R., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01896-09 · Cited by 48
Self-citationIncreased Functional Stability and Homogeneity of Viral Envelope Spikes through Directed Evolution
Leaman, D. P., & Zwick, M. B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003184 · Cited by 47
Wu, L., Zhou, T., Yang, Z., Svehla, K., O'Dell, S. J., Louder, M. K., Xu, L., Mascola, J. R., Burton, D. R., Hoxie, J. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02600-08 · Cited by 47
Self-citationProspects of HIV Env Modification as an Approach to HIV Vaccine Design
Hu, S.-L., & Stamatatos, L. (2007) · Current HIV Research · doi:10.2174/157016207782418542 · Cited by 46
Prospects for an HIV vaccine: leading B cells down the right path
Moir, S. L., Malaspina, A., & Fauci, A. S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2194 · Cited by 44
Kovacs, J. A., Vasudevachari, M. B., Easter, M., Davey, R. T., Falloon, J., Polis, M. A., Metcalf, J. A., Salzman, N. P., Baseler, M., & Smith, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116667 · Cited by 43
Pancera, M., Yang, Y., Louder, M. K., Gorman, J., Lu, G., McLellan, J. S., Stuckey, J., Zhu, J., Burton, D. R., Koff, W. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055701 · Cited by 40
Self-citationWu, X., Sambor, A., Nason, M., Yang, Z., Wu, L., Zolla‐Pazner, S., Nabel, G. J., & Mascola, J. R. (2008) · Virology · doi:10.1016/j.virol.2008.07.007 · Cited by 36
Self-citationXu, R., Srivastava, I. K., Kuller, L., Zarkikh, I., Kraft, Z., Fagrouch, Z. C., Letvin, N. L., Heeney, J. L., Barnett, S. W., & Stamatatos, L. (2006) · Virology · doi:10.1016/j.virol.2006.01.043 · Cited by 35
Joyce, M. G., Kanekiyo, M., Xu, L., Biertümpfel, C., Boyington, J. C., Moquin, S. A., Shi, W., Wu, X., Yang, Y., Yang, Z., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02717-12 · Cited by 35
Self-citationStamatos, N. M., Mascola, J. R., Kalyanaraman, V. S., Louder, M. K., Frampton, L. M., Birx, D. L., & VanCott, T. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9656-9667.1998 · Cited by 35
Self-citationAntigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design
Kong, L., & Sattentau, Q. J. (2012) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.s8-003 · Cited by 28
Cited by
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., et al. (2014) · Nature · doi:10.1038/nature13036 · Cited by 709
Self-citationPriming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
Jardine, J. G., Ota, T., Sok, D., Pauthner, M., Kulp, D. W., Kalyuzhniy, O., Skog, P. D., Thinnes, T. C., Bhullar, D., Briney, B., et al. (2015) · Science · doi:10.1126/science.aac5894 · Cited by 420
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
Steichen, J. M., Kulp, D. W., Tokatlian, T., Escolano, A., Dosenovic, P., Stanfield, R. L., McCoy, L. E., Ozorowski, G., Hu, X., Kalyuzhniy, O., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.016 · Cited by 401
Antibody responses to envelope glycoproteins in HIV-1 infection
Burton, D. R., & Mascola, J. R. (2015) · Nature Immunology · doi:10.1038/ni.3158 · Cited by 385
Self-citationFalkowska, E., Le, K. M., Ramos, A., Doores, K. J., Lee, J. H., Blattner, C., Ramirez, A., Derking, R., van Gils, M. J., Liang, C.-H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.009 · Cited by 359
Metadata
- Authors
- Mascola, J. R., & Haynes, B. F.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2013-06-16
- Volume
- 254
- Issue
- 1
- Pages
- 225-244
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2063195211
- Cited by
- 475
- References
- 190
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.